Lívia Bracht
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lívia Bracht has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Jurandir Fernando Comar
Universidade Estadual Maringá
15 shared publications - Adelar Bracht
Department of Biochemistry, Maringá State University, 5790 Avenida Colombo, Maringá 87020-900, Brazil
13 shared publications - Anacharis Babeto Sá-Nakanishi
Department of Biochemistry, State University of Maringá, Maringá, PR, Brazil
11 shared publications - Rosane Marina Peralta
Department of Biochemistry, Maringá State University, 5790 Avenida Colombo, Maringá 87020-900, Brazil
9 shared publications Adelar Bracht
Department of Biochemistry, State University of Maringá , 87020-900 Maringá, PR
8 shared publicationsAna Paula Ames-Sibin
Department of Biochemistry, State University of Maringá , 87020-900 Maringá, PR
5 shared publications
Latest Publications
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (9)
Clove oil-derived β-caryophyllene carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats
Objectives: β-Caryophyllene (β-Cary) exhibits anti-inflammatory and antioxidant activities. It can be obtained from clove oil, which is rich in eugenol; following eugenol removal, β-Cary can be isolated as the major constituent. However, the high lipophilicity of β-Cary limits its oral bioavailability. The present study investigated the anti-arthritic effects of β-Cary formulated in a self-nanoemulsifying drug delivery system (β-SNEDDS) in Holtzman rats with complete Freund’s adjuvant-induced arthritis, emphasizing articular inflammation and systemic oxidative stress. Methods: Healthy and adjuvant-induced arthritic rats received oral β-Cary or β-SNEDDS (50 or 100 mg/kg). Treatments were administered by oral gavage for 18 days after arthritis induction. Paw oedema, arthritis severity score, and articular leucocyte infiltration were assessed. Cartilage and growth plate integrity were evaluated by histological and histomorphometric analyses of the knee joint. Oxidative stress parameters, mRNA expression of cytokines and cachexia-related MuRF1, plasma markers of liver injury, and hepatic gluconeogenesis were also evaluated. Key findings: β-SNEDDS exhibited greater anti-arthritic efficacy than non-formulated β-Cary. β-SNEDDS (100 mg/kg) reduced paw oedema and arthritis score while preserving cartilage structure, and downregulated TNF-α, IL-1β, IL-6, and MuRF1 mRNA expression in periarticular skeletal muscle. In addition, β-SNEDDS restored most oxidative stress parameters altered by arthritis. Although free β-Cary improved selected oxidative stress parameters, β-SNEDDS showed a broader protective profile. Neither β-Cary nor β-SNEDDS induced hepatotoxicity, as demonstrated by unchanged plasma markers of liver injury and hepatic gluconeogenesis in healthy rats. Conclusions: Nanoemulsification enhanced the oral anti-arthritic efficacy and antioxidant activity of β-caryophyllene, supporting β-SNEDDS as a promising strategy for rheumatoid arthritis.
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (9)
Clove oil-derived β-caryophyllene carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats
Objectives: β-Caryophyllene (β-Cary) exhibits anti-inflammatory and antioxidant activities. It can be obtained from clove oil, which is rich in eugenol; following eugenol removal, β-Cary can be isolated as the major constituent. However, the high lipophilicity of β-Cary limits its oral bioavailability. The present study investigated the anti-arthritic effects of β-Cary formulated in a self-nanoemulsifying drug delivery system (β-SNEDDS) in Holtzman rats with complete Freund’s adjuvant-induced arthritis, emphasizing articular inflammation and systemic oxidative stress. Methods: Healthy and adjuvant-induced arthritic rats received oral β-Cary or β-SNEDDS (50 or 100 mg/kg). Treatments were administered by oral gavage for 18 days after arthritis induction. Paw oedema, arthritis severity score, and articular leucocyte infiltration were assessed. Cartilage and growth plate integrity were evaluated by histological and histomorphometric analyses of the knee joint. Oxidative stress parameters, mRNA expression of cytokines and cachexia-related MuRF1, plasma markers of liver injury, and hepatic gluconeogenesis were also evaluated. Key findings: β-SNEDDS exhibited greater anti-arthritic efficacy than non-formulated β-Cary. β-SNEDDS (100 mg/kg) reduced paw oedema and arthritis score while preserving cartilage structure, and downregulated TNF-α, IL-1β, IL-6, and MuRF1 mRNA expression in periarticular skeletal muscle. In addition, β-SNEDDS restored most oxidative stress parameters altered by arthritis. Although free β-Cary improved selected oxidative stress parameters, β-SNEDDS showed a broader protective profile. Neither β-Cary nor β-SNEDDS induced hepatotoxicity, as demonstrated by unchanged plasma markers of liver injury and hepatic gluconeogenesis in healthy rats. Conclusions: Nanoemulsification enhanced the oral anti-arthritic efficacy and antioxidant activity of β-caryophyllene, supporting β-SNEDDS as a promising strategy for rheumatoid arthritis.
- Open Access
- 19 August 2026
- Published by Wiley in Environmental Toxicology
Commercial Product Based on Metarhizium Anisopliae Affects Survival, Midgut Morphology, and Behavior in the Stingless Bee Scaptotrigona depilis (Hymenoptera: Apidae)
Brazilian social stingless bees are important pollinators and producers of honey, wax, royal jelly, propolis, and other products. These species are experiencing a population decline, attributed to different factors, such as the excessive use of pesticides. Biological control has been proposed as an alternative to chemical control, relying on the use of natural enemies to manage pests, including microorganisms such as entomopathogenic fungi. However, little is known about the effects of these agents on stingless bees. Therefore, this research evaluated the effect of the commercial bioproduct Metarhizium Oligos WP on the stingless bee Scaptotrigona depilis . After 5 and 10 days of exposure, the bees were cold‐immobilized and then dissected in saline solution, and the midgut was collected for histological and ultrastructural analyses. Injured organs were analyzed semiquantitatively. Additionally, superoxide dismutase (SOD) and catalase (CAT) activities were determined to investigate the occurrence of oxidative stress. Behavioral assessments were also performed. Although there were no significant changes in SOD and CAT activities, oxidative stress may have been induced, possibly due to the accumulation of reactive oxygen species and free radicals generated during fungal infection. These effects are believed to be the cause of the observed alterations in midgut morphology, as well as physiological and behavioral changes, such as impaired locomotion. The findings demonstrate the negative impact of the bioproduct on S. depilis stingless bees and suggest it may affect their pollination potential.
- 19 August 2026
- Published by Wiley in Environmental Toxicology
Open AccessCommercial Product Based on Metarhizium Anisopliae Affects Survival, Midgut Morphology, and Behavior in the Stingless Bee Scaptotrigona depilis (Hymenoptera: Apidae)
Brazilian social stingless bees are important pollinators and producers of honey, wax, royal jelly, propolis, and other products. These species are experiencing a population decline, attributed to different factors, such as the excessive use of pesticides. Biological control has been proposed as an alternative to chemical control, relying on the use of natural enemies to manage pests, including microorganisms such as entomopathogenic fungi. However, little is known about the effects of these agents on stingless bees. Therefore, this research evaluated the effect of the commercial bioproduct Metarhizium Oligos WP on the stingless bee Scaptotrigona depilis . After 5 and 10 days of exposure, the bees were cold‐immobilized and then dissected in saline solution, and the midgut was collected for histological and ultrastructural analyses. Injured organs were analyzed semiquantitatively. Additionally, superoxide dismutase (SOD) and catalase (CAT) activities were determined to investigate the occurrence of oxidative stress. Behavioral assessments were also performed. Although there were no significant changes in SOD and CAT activities, oxidative stress may have been induced, possibly due to the accumulation of reactive oxygen species and free radicals generated during fungal infection. These effects are believed to be the cause of the observed alterations in midgut morphology, as well as physiological and behavioral changes, such as impaired locomotion. The findings demonstrate the negative impact of the bioproduct on S. depilis stingless bees and suggest it may affect their pollination potential.
- 31 October 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (2)
Improving the oral bioavailability and anti-inflammatory potential of clove oil-derived β-caryophyllene with a self-nanoemulsifying drug delivery system
Objectives: β-Caryophyllene (β-Cary) is known for its anti-inflammatory properties and offers a promising avenue for drug development. This study prepared a lipid-based self-emulsifying system containing clove oil-derived β-Cary and investigated its bioavailability and anti-inflammatory effects upon oral administration in rats. Methods: The formulation (β-SNEDDS), composed of β-Cary, surfactant, and lipophilic phase, was evaluated as size, morphology, and rheology. Key findings: β-SNEDDS exhibited Newtonian flow and formed spherical droplets (≈100 nm) in water and phosphate-buffered saline (pH 6.8), with a diameter ~15% higher in PBS, likely due to ionic strength affecting surfactant hydration and interfacial structure. Transmission electron microscopy confirmed spherical particles in simulated gastrointestinal medium. β-SNEDDS showed twice the oral bioavailability of β-Cary. This phenomenon allowed β-SNEDDS to reduce carrageenan-induced paw edema and pleural polymorphonuclear leukocyte recruitment in the pleural cavity of rats, showing greater efficacy than β-Cary. Furthermore, β-Cary reduced N-Formyl-Met-Leu-Phe (fMLP)-induced leukocyte chemotaxis in vitro, and oral β-SNEDDS or β-Cary reduced rolling and adherent leukocytes in situ in rat microvascular endothelium. Notably, β-SNEDDS exhibited a more pronounced effect on rolling behavior. Conclusions: β-Cary showed significant anti-inflammatory activity by inhibiting leukocyte migration to the inflamed site. Its β-SNEDDS formulation improved oral bioavailability and additional anti-inflammatory parameters in vivo, beyond those achieved by β-Cary, supporting this approach as a promising oral strategy.
- 31 October 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (2)
Improving the oral bioavailability and anti-inflammatory potential of clove oil-derived β-caryophyllene with a self-nanoemulsifying drug delivery system
Objectives: β-Caryophyllene (β-Cary) is known for its anti-inflammatory properties and offers a promising avenue for drug development. This study prepared a lipid-based self-emulsifying system containing clove oil-derived β-Cary and investigated its bioavailability and anti-inflammatory effects upon oral administration in rats. Methods: The formulation (β-SNEDDS), composed of β-Cary, surfactant, and lipophilic phase, was evaluated as size, morphology, and rheology. Key findings: β-SNEDDS exhibited Newtonian flow and formed spherical droplets (≈100 nm) in water and phosphate-buffered saline (pH 6.8), with a diameter ~15% higher in PBS, likely due to ionic strength affecting surfactant hydration and interfacial structure. Transmission electron microscopy confirmed spherical particles in simulated gastrointestinal medium. β-SNEDDS showed twice the oral bioavailability of β-Cary. This phenomenon allowed β-SNEDDS to reduce carrageenan-induced paw edema and pleural polymorphonuclear leukocyte recruitment in the pleural cavity of rats, showing greater efficacy than β-Cary. Furthermore, β-Cary reduced N-Formyl-Met-Leu-Phe (fMLP)-induced leukocyte chemotaxis in vitro, and oral β-SNEDDS or β-Cary reduced rolling and adherent leukocytes in situ in rat microvascular endothelium. Notably, β-SNEDDS exhibited a more pronounced effect on rolling behavior. Conclusions: β-Cary showed significant anti-inflammatory activity by inhibiting leukocyte migration to the inflamed site. Its β-SNEDDS formulation improved oral bioavailability and additional anti-inflammatory parameters in vivo, beyond those achieved by β-Cary, supporting this approach as a promising oral strategy.
- Open Access
- 7 September 2025
- Published by Wiley in FEBS Open Bio
- Vol. 16 (1) , 199-221
Short‐term actions of epigalocatechin‐3‐gallate in the liver: a mechanistic insight into hypoglycemic and potential toxic effects
Epigallocatechin‐3‐gallate (EGCG), the main catechin in green tea, is associated with antidiabetic and anti‐obesity effects, although its acute hepatic actions remain unclear. We investigated short‐term effects of EGCG (10–500 μ m ) using isolated perfused rat livers and complementary assays in mitochondrial, microsomal, and cytosolic fractions. EGCG markedly inhibited gluconeogenesis from lactate (up to 52%), glycerol (33%), and alanine (47%), while it stimulated glycolysis, glycogenolysis, and oleic acid oxidation (+42% total ketone bodies). Oxygen uptake was stimulated under glycogenolytic and fatty acid oxidizing conditions but inhibited under gluconeogenic conditions. Mechanistic analyses revealed EGCG‐induced mild mitochondrial uncoupling, inhibition of pyruvate carboxylase and glucose‐6‐phosphatase (with no effect on fructose‐1,6‐bisphosphatase) and stimulation of phosphoenolpyruvate carboxykinase. EGCG shifted cytosolic and mitochondrial NADH/NAD + ratios toward oxidation, increased mitochondrial and plasma membrane permeability (LDH leakage from 10 μ m ), and altered redox‐sensitive fluxes, while the total hepatic ATP content remained unchanged. In summary, EGCG's multifaceted actions suggest that suppression of gluconeogenesis may contribute to its antihyperglycemic effect and the stimulation of fatty acid oxidation to its anti‐obesity action. Finally, EGCG's membrane‐disruptive properties raise concerns about potential hepatotoxicity in compromised livers.
- 7 September 2025
- Published by Wiley in FEBS Open Bio
- Vol. 16 (1) , 199-221
Open AccessShort‐term actions of epigalocatechin‐3‐gallate in the liver: a mechanistic insight into hypoglycemic and potential toxic effects
Epigallocatechin‐3‐gallate (EGCG), the main catechin in green tea, is associated with antidiabetic and anti‐obesity effects, although its acute hepatic actions remain unclear. We investigated short‐term effects of EGCG (10–500 μ m ) using isolated perfused rat livers and complementary assays in mitochondrial, microsomal, and cytosolic fractions. EGCG markedly inhibited gluconeogenesis from lactate (up to 52%), glycerol (33%), and alanine (47%), while it stimulated glycolysis, glycogenolysis, and oleic acid oxidation (+42% total ketone bodies). Oxygen uptake was stimulated under glycogenolytic and fatty acid oxidizing conditions but inhibited under gluconeogenic conditions. Mechanistic analyses revealed EGCG‐induced mild mitochondrial uncoupling, inhibition of pyruvate carboxylase and glucose‐6‐phosphatase (with no effect on fructose‐1,6‐bisphosphatase) and stimulation of phosphoenolpyruvate carboxykinase. EGCG shifted cytosolic and mitochondrial NADH/NAD + ratios toward oxidation, increased mitochondrial and plasma membrane permeability (LDH leakage from 10 μ m ), and altered redox‐sensitive fluxes, while the total hepatic ATP content remained unchanged. In summary, EGCG's multifaceted actions suggest that suppression of gluconeogenesis may contribute to its antihyperglycemic effect and the stimulation of fatty acid oxidation to its anti‐obesity action. Finally, EGCG's membrane‐disruptive properties raise concerns about potential hepatotoxicity in compromised livers.
- 21 June 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 352, 120179
An in vitro, in vivo and in silico assessment of fat absorption inhibition by a gymnemic acid rich extract of Gymnema sylvestre leaves
- 21 June 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 352, 120179
An in vitro, in vivo and in silico assessment of fat absorption inhibition by a gymnemic acid rich extract of Gymnema sylvestre leaves
- 17 February 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (5) , 1969-1991
Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity
Schematic representation of the action mechanisms and phytochemicals in Tamarindus indica waste for managing diabetes and obesity.
- 17 February 2025
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 16 (5) , 1969-1991
Tamarindus indica sub-products as potential tools for simultaneous management of diabetes and obesity
Schematic representation of the action mechanisms and phytochemicals in Tamarindus indica waste for managing diabetes and obesity.
- 30 January 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 77 (3) , 371-385
Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats
Objectives: Copaiba essential oil (CEO) is obtained through the distillation of copaiba balsam and has been used in the traditional medicine to treat inflammatory conditions. However, the highly lipophilic nature of CEO restricts its pharmaceutical use. This study evaluated the effect of CEO, carried in a self-nanoemulsifying drug delivery system (SNEDDS), on articular and systemic inflammation and liver changes in Holtzman rats with Freund’s adjuvant-induced arthritis. Methods: Healthy and arthritic rats received orally for 18 days the non-formulated CEO and the one carried in a self-nanoemulsifying drug delivery system (FSNEDDS), both at doses of 50 and 100 mg/kg. The oral bioavailability of FSNEDDS was determined in healthy rats by quantifying the levels of β-caryophyllene in the plasma. Key findings: FSNEDDS exhibited more than three times greater oral bioavailability compared to non-formulated CEO. This phenomenon allowed FSNEDDS (100 mg/kg) to effectively reduce adjuvant-induced articular and systemic inflammation and oxidative stress in arthritic rats at a dose four times lower than copaiba balsam and β-caryophyllene. Furthermore, FSNEDDS did not alter the serum markers of liver damage, hepatic morphometry, and liver gluconeogenesis in healthy rats. Conclusion: FSNEDDS was effective against arthritis in rats, and unlike copaiba balsam, it does not exhibit hepatotoxicity, suggesting it could serve as a phytotherapeutic alternative in the treatment of rheumatoid arthritis.
- 30 January 2025
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 77 (3) , 371-385
Copaiba essential oil carried in a self-nanoemulsifying drug delivery system improves adjuvant-induced arthritis in rats
Objectives: Copaiba essential oil (CEO) is obtained through the distillation of copaiba balsam and has been used in the traditional medicine to treat inflammatory conditions. However, the highly lipophilic nature of CEO restricts its pharmaceutical use. This study evaluated the effect of CEO, carried in a self-nanoemulsifying drug delivery system (SNEDDS), on articular and systemic inflammation and liver changes in Holtzman rats with Freund’s adjuvant-induced arthritis. Methods: Healthy and arthritic rats received orally for 18 days the non-formulated CEO and the one carried in a self-nanoemulsifying drug delivery system (FSNEDDS), both at doses of 50 and 100 mg/kg. The oral bioavailability of FSNEDDS was determined in healthy rats by quantifying the levels of β-caryophyllene in the plasma. Key findings: FSNEDDS exhibited more than three times greater oral bioavailability compared to non-formulated CEO. This phenomenon allowed FSNEDDS (100 mg/kg) to effectively reduce adjuvant-induced articular and systemic inflammation and oxidative stress in arthritic rats at a dose four times lower than copaiba balsam and β-caryophyllene. Furthermore, FSNEDDS did not alter the serum markers of liver damage, hepatic morphometry, and liver gluconeogenesis in healthy rats. Conclusion: FSNEDDS was effective against arthritis in rats, and unlike copaiba balsam, it does not exhibit hepatotoxicity, suggesting it could serve as a phytotherapeutic alternative in the treatment of rheumatoid arthritis.
- Open Access
Biotechnological, Nutritional, and Therapeutic Applications of Quinoa (Chenopodium quinoa Willd.) and Its By-Products: A Review of the Past Five-Year Findings
This study aimed to provide an updated critical review of the nutritional, therapeutic, biotechnological, and environmental aspects involved in the exploitation of Chenopodium quinoa Willd and its biowastes. Special attention was devoted to investigations of the therapeutic and nutritional properties of different parts and varieties of quinoa as well as of the use of the biowaste resulting from the processing of grain. Studies published from 2018 onward were prioritized. Extracts and fractions obtained from several Chenopodium quinoa matrices showed antioxidant, antidiabetic, immunoregulatory, neuroprotective, and antimicrobial effects in in vitro and in vivo models and some clinical studies. The activities were attributed to the presence of phytochemicals such as polyphenols, saponins, peptides, polysaccharides, and dietary fibers. Quinoa wastes are abundant and low-cost sources of bioactive molecules for the development of new drugs, natural antioxidants, preservatives, dyes, emulsifiers, and carriers for food and cosmetics applications. Among the demands to be fulfilled in the coming years are the following: (1) isolation of new bioactive phytochemicals from quinoa varieties that are still underexploited; (2) optimization of green approaches to the sustainable recovery of compounds of industrial interest from quinoa by-products; and (3) well-conducted clinical trials to attest safety and efficacy of extracts and compounds.
Open AccessBiotechnological, Nutritional, and Therapeutic Applications of Quinoa (Chenopodium quinoa Willd.) and Its By-Products: A Review of the Past Five-Year Findings
This study aimed to provide an updated critical review of the nutritional, therapeutic, biotechnological, and environmental aspects involved in the exploitation of Chenopodium quinoa Willd and its biowastes. Special attention was devoted to investigations of the therapeutic and nutritional properties of different parts and varieties of quinoa as well as of the use of the biowaste resulting from the processing of grain. Studies published from 2018 onward were prioritized. Extracts and fractions obtained from several Chenopodium quinoa matrices showed antioxidant, antidiabetic, immunoregulatory, neuroprotective, and antimicrobial effects in in vitro and in vivo models and some clinical studies. The activities were attributed to the presence of phytochemicals such as polyphenols, saponins, peptides, polysaccharides, and dietary fibers. Quinoa wastes are abundant and low-cost sources of bioactive molecules for the development of new drugs, natural antioxidants, preservatives, dyes, emulsifiers, and carriers for food and cosmetics applications. Among the demands to be fulfilled in the coming years are the following: (1) isolation of new bioactive phytochemicals from quinoa varieties that are still underexploited; (2) optimization of green approaches to the sustainable recovery of compounds of industrial interest from quinoa by-products; and (3) well-conducted clinical trials to attest safety and efficacy of extracts and compounds.
- 1 January 2024
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 102 (01) , 42-54
Effects of a high-fat low-carbohydrate diet under different energy conditions on glucose homeostasis and fatty liver development in rats and on gluconeogenesis in the isolated perfused liver
The beneficial effects of high-fat low-carbohydrate (HFLC) diets on glucose metabolism have been questioned and their effects on liver metabolism are not totally clear. The aim of this work was to investigate the effects of an HFLC diet under different energy conditions on glucose homeostasis, fatty liver development, and hepatic gluconeogenesis using the isolated perfused rat liver. HFLC diet (79% fat, 19% protein, and 2% carbohydrates in Kcal%) was administered to rats for 4 weeks under three conditions: ad libitum (hypercaloric), isocaloric, and hypocaloric (energy reduction of 20%). Fasting blood glucose levels and total fat in the liver were higher in all HFLC diet rats. Oral glucose tolerance was impaired in isocaloric and hypercaloric groups, although insulin sensitivity was not altered. HFLC diet also caused marked liver metabolic alterations: higher gluconeogenesis rate from lactate and a reduced capacity to metabolize alanine, the latter effect being more intense in the hypocaloric condition. Thus, even when HFLC diets are used for weight loss, our data imply that they can potentially cause harmful consequences for the liver.
- 1 January 2024
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 102 (01) , 42-54
Effects of a high-fat low-carbohydrate diet under different energy conditions on glucose homeostasis and fatty liver development in rats and on gluconeogenesis in the isolated perfused liver
The beneficial effects of high-fat low-carbohydrate (HFLC) diets on glucose metabolism have been questioned and their effects on liver metabolism are not totally clear. The aim of this work was to investigate the effects of an HFLC diet under different energy conditions on glucose homeostasis, fatty liver development, and hepatic gluconeogenesis using the isolated perfused rat liver. HFLC diet (79% fat, 19% protein, and 2% carbohydrates in Kcal%) was administered to rats for 4 weeks under three conditions: ad libitum (hypercaloric), isocaloric, and hypocaloric (energy reduction of 20%). Fasting blood glucose levels and total fat in the liver were higher in all HFLC diet rats. Oral glucose tolerance was impaired in isocaloric and hypercaloric groups, although insulin sensitivity was not altered. HFLC diet also caused marked liver metabolic alterations: higher gluconeogenesis rate from lactate and a reduced capacity to metabolize alanine, the latter effect being more intense in the hypocaloric condition. Thus, even when HFLC diets are used for weight loss, our data imply that they can potentially cause harmful consequences for the liver.
- 19 December 2023
- Published by Elsevier in Food Research International
- Vol. 178, 113878
Characterization and bioactivities of coffee husks extract encapsulated with polyvinylpyrrolidone
- 19 December 2023
- Published by Elsevier in Food Research International
- Vol. 178, 113878
Characterization and bioactivities of coffee husks extract encapsulated with polyvinylpyrrolidone